Neuroplasticity: The Continuum of Change

Neuroplasticity has moved from a technical neuroscience term into widespread public usage, but that popular usage often simplifies or misstates the concept. Wallace and colleagues note that although neuroplasticity broadly denotes the nervous system's capacity to change in response to stimuli, it encompasses a complex continuum of molecular, cellular and circuit-level processes whose effects ultimately shape behaviour. The authors argue that this breadth has led to ambiguity in both scientific and public discourse. To clarify this multifaceted concept for readers of ACS Chemical Neuroscience, the paper brings together concise perspectives from experts across scientific disciplines. The study solicited short, off-the-cuff definitions and reactions to the prompt "When you hear the term 'neuroplasticity', what are the first thoughts that come to mind?" and uses these quotations to illustrate how neuroplasticity links ions and molecules to cells, circuits and behaviour. The stated aim is to present a coherent, holistic framing of neuroplasticity as a continuum of change that is relevant to health and disease.

This piece is a Viewpoint synthesising expert reactions rather than an empirical study or systematic review. Wallace and colleagues gathered brief, informal definitions and impressions from researchers across multiple fields to capture diverse ways of thinking about neuroplasticity. The prompt given to contributors was: "When you hear the term 'neuroplasticity', what are the first thoughts that come to mind?" and selected quotations are presented to illuminate conceptual points. The extracted text does not report systematic details about the methods used to solicit or select contributors, such as the number of experts, sampling strategy, response rate, or any formal analytical procedure for integrating the responses. There is no description of quantitative analyses or predefined outcome measures because the manuscript is framed as a conceptual overview drawing on expert commentary rather than a dataset-driven investigation.

The authors organise the discussion into themed sections that elaborate how neuroplasticity manifests across different contexts. In "Plasticity over the lifetime" they contrast the widespread, dynamic synaptogenesis and pruning of neurodevelopment with the generally more constrained plasticity of the adult brain. Repetition and the value of an experience shape the extent of lasting change, and some capacities show critical or sensitive periods when change is much easier or effectively irreversible. Mechanistically, adult changes are described as modifications of interneuronal interactions via neurons and glia, including structural remodelling, changes in synaptic weight and shifts in intrinsic excitability. Age-related synapse loss is noted as a contributor to cognitive decline, and genetic and environmental factors can accelerate neuronal atrophy in neurodegenerative diseases. Under "Experience-dependent plasticity" the paper highlights how life events mould circuitry for both adaptive and maladaptive outcomes. Positive learning, growth or transformative experiences can produce beneficial neural change, whereas chronic stress and trauma can cause cortical and hippocampal atrophy and relative amygdala hypertrophy, contributing to conditions such as depression and PTSD. The authors cite experimental findings showing a transient period of heightened plasticity after brain injury that promotes axonal sprouting, observed in animal models and in humans. Substance exposure is described as another powerful driver of maladaptive plasticity: as Dr Nora Volkow is quoted, "drugs strengthen neuronal connectivity in reward and memory circuits that ultimately drive conditioning and the enhanced motivational value of drugs in addiction." In the section labelled "Disease," simple lifestyle factors—sleep, diet, meditation and exercise—are presented as cost-effective ways to support adaptive plasticity, while clinical interventions aim to harness plasticity therapeutically. The authors mention neuromodulation techniques such as transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT), and they refer to emerging pharmacological agents termed psychoplastogens. A key translational challenge emphasised is achieving circuit-selective control of plasticity so that beneficial changes can be promoted without engendering maladaptive rewiring.

Wallace and colleagues conclude that "neuroplasticity" is best understood as a multiscale continuum linking molecular interactions through cellular and circuit processes to overt behaviour. At the cellular level it encompasses subtypes such as structural plasticity, synaptic plasticity, intrinsic excitability and metaplasticity; together these dynamic changes underlie learning, memory and homeostatic control of circuit excitability, as remarked by Rick Huganir. The Viewpoint stresses that neuroplasticity can be either adaptive or maladaptive depending on context, that it varies across the lifespan, and that both simple lifestyle interventions and more advanced neuromodulatory or pharmacological approaches aim to harness these mechanisms for health. Finally, the authors acknowledge the term's broadness and the resulting ambiguity in discourse, and they present their synthesis as an introductory framework to help scientists and the public appreciate why neuroplasticity is conceptually rich yet difficult to encapsulate in a single definition.